Bacillus calmette-guérin vaccination in a patient treated with infliximab.
Toussirot
Eric
E
Wendling
Daniel
D
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001500:BCG Vaccine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000069285:Infliximab; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D014611:Vaccination / Q000009:adverse effects
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D001500:BCG Vaccine; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab